Man Group PLC Otonomy, Inc. Transaction History

Man Group PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$2.49 - $6.23 $70,340 - $175,991	-28,249 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$3.48 - $6.47 $166,413 - $309,395	-47,820 Reduced 62.86%	28,249 $183,000
Q3 2020 Nov 16, 2020	BUY	$3.16 - $4.36 $22,120 - $30,520	7,000 Added 10.13%	76,069 $308,000
Q2 2020 Aug 14, 2020	SELL	$1.87 - $3.84 $8,501 - $17,456	-4,546 Reduced 6.18%	69,069 $250,000
Q1 2020 May 15, 2020	SELL	$1.58 - $4.06 $58,973 - $151,539	-37,325 Reduced 33.64%	73,615 $145,000
Q4 2019 Feb 18, 2020	SELL	$2.13 - $3.83 $426 - $766	-200 Reduced 0.18%	110,940 $425,000
Q3 2019 Nov 14, 2019	SELL	$2.12 - $2.86 $83,740 - $112,970	-39,500 Reduced 26.22%	111,140 $266,000
Q2 2019 Aug 14, 2019	BUY	$2.35 - $3.09 $15,275 - $20,085	6,500 Added 4.51%	150,640 $414,000
Q1 2019 May 15, 2019	SELL	$1.8 - $2.97 $6,480 - $10,692	-3,600 Reduced 2.44%	144,140 $379,000
Q4 2018 Feb 14, 2019	SELL	$1.51 - $2.93 $300,524 - $583,137	-199,023 Reduced 57.39%	147,740 $273,000
Q3 2018 Nov 14, 2018	SELL	$2.6 - $3.95 $194,269 - $295,140	-74,719 Reduced 17.73%	346,763 $954,000
Q2 2018 Aug 14, 2018	BUY	$3.7 - $4.75 $143,863 - $184,689	38,882 Added 10.16%	421,482 $1.62 Million
Q1 2018 May 15, 2018	BUY	$4.05 - $6.1 $1.55 Million - $2.33 Million	382,600 New	382,600 $1.61 Million

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.